Hormone blocker aims to pause early puberty in children
NCT ID NCT06926933
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This trial tests a long-acting injection of leuprolide acetate in children with central precocious puberty, a condition where puberty starts too early. The goal is to suppress puberty-related hormones, slowing or stopping early development. The study includes children aged 4 to 9 (girls) or 4 to 10 (boys) who have not yet received treatment. Researchers will measure hormone levels to see if the drug works and monitor for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- leuprolide acetate
- What this could lead to
- If successful, this could provide a safe and effective way to pause early puberty in children, allowing them to grow at a normal pace.
- What could go wrong
- This is a small, single-group study, so results may not apply to all children. The drug may cause side effects like injection site reactions or temporary hormone changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL PRECOCIOUS PUBERTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ajou University Medical Center
Suwon, South Korea
-
Asan Medical Center
Seoul, South Korea
-
Chosun University Hospital
Kwangju, South Korea
-
Gangnam Severance Hospital
Seoul, South Korea
-
Jeonbuk National University Hospital
Jeonju, South Korea
-
Kangdong Sacred Heart Hospital
Seoul, South Korea
-
Korea University Ansan Hospital
Ansan, South Korea
-
Kyung Hee University Hospital At Gangdong
Seoul, South Korea
-
Seoul National University Bundang Hospital
Seongnam, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.